- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07179224
Investigating Brain Response Patterns to Non-Invasive Magnetic Stimulation Therapy
This clinical study explores how the brain responds to a specialized form of non-invasive therapy called repetitive transcranial magnetic stimulation (rTMS) using the EXOMIND device. Unlike medication-based treatments, this approach uses magnetic fields to gently stimulate specific areas of the brain, offering a potential alternative for various neurological conditions without the need for surgery or systemic drugs.
The study will carefully monitor 15 adult participants as they undergo a single treatment session with close follow-up over approximately two months. Before the treatment begins, researchers will record baseline brain activity using EEG (electroencephalography) while participants rest with their eyes closed and open. This establishes a reference point to compare how brain activity changes after stimulation.
During the treatment session, the stimulation intensity will be personalized to each participant's comfort level, never exceeding safety thresholds. The device will target different locations in the prefrontal cortex—the brain region involved in complex thinking, decision-making, and mood regulation. Researchers will measure electrical brain activity after stimulating each location to understand how different brain areas respond to the treatment.
Patient comfort and safety are top priorities in this study. Participants will complete comfort questionnaires rating their experience during treatment, including any discomfort or pain. The research team will carefully monitor for any side effects immediately after treatment and during follow-up visits at two weeks and one month. This thorough safety monitoring ensures that any concerns are promptly addressed while contributing valuable data about the treatment's tolerability.
This research is particularly important because it represents a patient-centered approach to neurological treatment development. By studying how different brain regions respond to stimulation and gathering direct feedback from participants about their comfort, researchers can work toward developing more effective and better-tolerated therapies. The findings could help optimize treatment protocols for various neurological and psychiatric conditions where non-invasive brain stimulation shows promise.
For patients and caregivers considering participation, this study offers several important safeguards. The exclusion criteria carefully screen out individuals who might be at higher risk, such as those with certain medical implants, seizure disorders, or specific medical conditions. The inclusion criteria ensure participants are stable in their current treatments and committed to following study requirements. The open-label design means everyone knows what treatment they're receiving, maintaining transparency throughout the process.
Research in non-invasive brain stimulation represents a growing frontier in neurological and psychiatric treatment. Unlike medications that affect the entire body, targeted stimulation approaches like rTMS offer the potential for more specific effects with fewer systemic side effects. Studies like this one contribute to building the scientific foundation needed to make these treatments more effective, predictable, and accessible to patients who might benefit from them.
The measurement of brain activity through EEG provides objective data about how the brain responds to stimulation, while patient questionnaires capture the subjective experience of treatment. This combination of objective and subjective measures helps researchers develop treatments that are not only effective but also comfortable and practical for clinical use. The knowledge gained could eventually help clinicians personalize stimulation protocols based on individual brain characteristics and patient preferences.
As neurological and mental health conditions affect millions worldwide, research into non-pharmacological treatments becomes increasingly valuable. Many patients cannot tolerate or do not respond adequately to available medications, creating an urgent need for alternative approaches. Studies investigating brain stimulation techniques contribute to expanding the treatment options available to clinicians and patients, potentially improving quality of life for those living with challenging neurological conditions.
Upcoming Clinical Trials
-
NCT07814352RecruitingLeptomeningeal Disease (LMD)
-
NCT07814378Not yet recruitingAnemia | Pregnancy | Iron Deficiency Anaemia in Childbirth
-
NCT07814391Not yet recruitingPeri-Implantitis and Peri-implant Mucositis
-
NCT07814404Not yet recruiting
-
NCT07814417Not yet recruiting
-
NCT07814443Not yet recruiting
-
NCT07814456RecruitingInflammatory Bowel Disease | Ulcerative Colitis (UC)
-
NCT07814495Not yet recruiting
-
NCT07814508RecruitingDiabetes Mellitus | Diabetes Mellitus Type 2 | Sleep Quality | Ecological Momentary Assessment | Continuous Glucose Monitoring System | Diabetes (DM) | Diabetes Distress | Fear of Hypoglycemia | Diabetes Mellitus Type 1 | Glycemic Responses
-
NCT07814534Not yet recruitingParkinson Disease (PD)
-
NCT07814547RecruitingCarpal Tunnel Syndrome (CTS)